Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

AGM Statement

18 Mar 2011 07:41

RNS Number : 2004D
Samsung Electronics Co. Ld
18 March 2011
Β 

ο»Ώ

Β 

Β 

Β 

Β 

Β 

42nd AGM Results

Β 

The 42nd annual general meeting of shareholders was held on March 18, 2011, and all the agendas were approved as submitted in their original forms.

Β 

Β 

β–« Details

Β 

1. Agenda Item No.1: approved

Β 

Β - Approval of Balance Sheet, Income Statement, and Statement of Appropriation of

Retained Earnings (Draft) for the 42ndΒ Fiscal Year (from Jan 1, 2010 to Dec 31, 2010)

Β 

β€’ Total assets: KRW 107,179,005 million

β€’ Total liabilities: KRW 27,211,834 million

β€’ Capital stock: KRW 897,514 million

β€’ Total shareholders' equity: KRW 79,967,171 million

β€’ Sales: KRW 112,249,475 million

β€’ Operating profit: KRW 14,924,141 million

β€’ Net income: KRW 13,236,461 million

β€’ Earnings per share: KRW 88,799

- Cash Dividends:

Β 

β€’ Year-end dividend: KRW 5,000 (common), KRW 5,050 (preferred)

β€’ Interim dividend: KRW 5,000 (common), KRW 5,000 (preferred)

β€’ Total payout: KRW 1,496,539 million

β€’ Dividend rate (interim + year-end dividends): 1.07% (common share),

1.58% (preferred share)

Β 

2. Agenda Item No. 2: approved

Β 

Β - Approval of the Compensation Ceiling for the Directors

Β 

β€’ Proposed remuneration ceiling for the 43rd fiscal year: KRW 37 billion

* Remuneration ceiling approved in the 42nd fiscal year: KRW 52 billion

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMDKFDQOBKKDND
Date   Source Headline
29th Aug 20258:57 amRNS2025 Half-year Business Report
31st Jul 20259:49 amRNSReport on Share Disposition Results
31st Jul 20259:48 amRNSTransaction with Affilliate Company
31st Jul 20258:55 amRNSSingle Sale and Supply Contract - Replacement
31st Jul 20257:00 amRNSQuarterly Dividend for Second Quarter 2025
31st Jul 20257:00 amRNS2025 2Q Earnings Release
28th Jul 20259:19 amRNSSingle Sale and Supply Contract
25th Jul 20259:53 amRNSDecision on Share Disposition
8th Jul 20258:11 amRNSDecision on Share Repurchase
8th Jul 20257:15 amRNSNotice of 2Q 2025 Earning Release schedule
8th Jul 20257:09 amRNS2Q 2025 Pre-Earnings Guidance
27th Jun 20258:51 amRNSSustainability Report 2025
30th May 20259:58 amRNSCorporate Governance Report FY2024
30th May 20259:49 amRNS2025 1Q Interim Business Report
28th May 202510:10 amRNSReport on Share Disposition Results
23rd May 20259:36 amRNSDecision on Share Disposition
16th May 20259:34 amRNSReport on Share Repurchase Results
30th Apr 20259:05 amRNS2024 Business Report
30th Apr 20258:45 amRNSCharitable Contribution
30th Apr 20258:42 amRNSTransactions with Affiliated Companies
30th Apr 20257:00 amRNS2025 1Q Earnings Release
30th Apr 20257:00 amRNSQuarterly Dividend for First Quarter 2025
8th Apr 20257:00 amRNSNotice of 1Q 2025 Earning Release schedule
8th Apr 20257:00 amRNS1Q 2025 Pre-Earnings Guidance
26th Mar 20257:00 amRNSNotice on Change of Chief Executive Officer
19th Mar 20258:16 amRNSAppointment of New Chief Executive Officer
19th Mar 20258:11 amRNSResults of the 56th Annual General Meeting
18th Feb 202510:21 amRNSDecision on Share Repurchase
18th Feb 202510:07 amRNSCharitable Contribution
18th Feb 20259:57 amRNSDecision on Cancellation of Shares
18th Feb 20259:14 amRNSReference Material for 2025 AGM
18th Feb 20259:01 amRNS2024 Separate Financial Statements
18th Feb 20258:58 amRNS2024 Consolidated Financial Statements
17th Feb 202512:16 pmRNSReport on Share Repurchase Results
13th Feb 20259:12 amRNSFinal Delisting and Listing of Stocks
13th Feb 20258:42 amRNSAdmission to Trading
10th Feb 202512:05 pmRNSNotice of Approval and Publication of Prospectus
31st Jan 20257:00 amRNS2024 4Q Earning Release
31st Jan 20257:00 amRNSYear-End Dividend for FY2024
31st Jan 20257:00 amRNSAnnouncement of Capex Result for FY2024
8th Jan 20257:00 amRNS4Q 2024 Pre-Earnings Guidance
8th Jan 20257:00 amRNSNotice of 4Q 2024 Earning Release
23rd Dec 20247:00 amRNSInvestment in New Semiconductor Plant in Texas, US
29th Nov 20248:01 amRNSCharitable Contribution
29th Nov 20247:55 amRNS2024 3Q Interim Business Report
29th Nov 20247:41 amRNSTransaction with Affiliate Company
26th Nov 202410:01 amRNSDelisting of GDR from the LuxembourgStockExchange
18th Nov 20249:22 amRNSDecision on Share Repurchase Plan
4th Nov 202410:05 amRNSDelisting Announcement
31st Oct 20249:14 amRNSCharitable Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.